HCMT
RPRX icon

Highland Capital Management (Tennessee)’s Royalty Pharma RPRX Stock Holding History

Highland Capital Management (Tennessee)’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-52,094
Closed -$2.03M – 342
2022
Q1 		$2.03M Buy
52,094
+689
+1% +$27.1K 0.12% 175
2021
Q4 		$2.05M Sell
51,405
-5,449
-10% -$212K 0.12% 178
2021
Q3 		$2.06M Buy
+56,854
New +$2.21M 0.12% 177

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SGA
Siguler Guff Advisers New York $56.1M AUM 46.63% 1-Year Est. Return

Highland Capital Management (Tennessee)'s RPRX Position: Q2 2022 in Review

Highland Capital Management (Tennessee) sold out of Royalty Pharma (RPRX) in Q2 2022, closing a stake of 52,094 shares — an estimated $2.03M sold.

Highland Capital Management (Tennessee) first reported a position in RPRX in Q3 2021 and held it in 3 quarters. The position peaked at $2.06M in Q3 2021. 283 funds tracked by Wall St. Rank hold RPRX as of Q2 2022.

  • Highland Capital Management (Tennessee) reported no remaining Royalty Pharma position as of Q2 2022 after selling out during the quarter.
  • Highland Capital Management (Tennessee) sold 52,094 Royalty Pharma shares in Q2 2022, an estimated $2.03M.
  • Highland Capital Management (Tennessee) first reported a position in Royalty Pharma in Q3 2021 and held it in 3 quarters.
  • Highland Capital Management (Tennessee)'s Royalty Pharma position peaked at $2.06M in Q3 2021.
  • 283 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2022.

Based on Highland Capital Management (Tennessee)'s 13F filing for Q2 2022, filed 14 Jul 2022.